<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01234207</url>
  </required_header>
  <id_info>
    <org_study_id>CZV_PAL1</org_study_id>
    <nct_id>NCT01234207</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle</brief_title>
  <acronym>CZV_PAL1</acronym>
  <official_title>Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Carl Zeiss Meditec, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Berkeley</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare objective clinical measures of visual performance
      and subjective measures of satisfaction and preference between standard progressive addition
      lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL
      spectacle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-masked crossover trial, 95 experienced wearers wore customized free-form PAL
      spectacles (Test) and standard non-free-form PAL spectacles (Control) for one week each. All
      subjects wore both Test and Control spectacles, and the pair to be worn first was randomly
      assigned. At dispensing and after 1 week of wear, subjects were tested for distance and near
      visual acuity (VA) under both high and low contrast; in addition, 30 degree off-axis VA was
      measured using a novel apparatus, as was the horizontal extent of undistorted vision at
      reading distance. Subjects also completed a set of questionnaires detailing their
      satisfaction levels, adaptation times, and preferences for Test or Control spectacles for
      different visual tasks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity, High Contrast, Distance Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity, Low Contrast, Distance Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity, High Contrast, Near Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity, Low Contrast, Near Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>30-degree Off-axis Distance Visual Acuity, High Contrast Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
  </primary_outcome>
  <primary_outcome>
    <measure>30-degree Off-axis Distance Visual Acuity, Low Contrast Chart</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Horizontal Extent of Undistorted Vision at Reading Distance</measure>
    <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
    <description>Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Battery</measure>
    <time_frame>At study exit, after both Test and Control spectacles had been worn for 1 week each</time_frame>
    <description>Forced-choice Likert scale preference questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Randomized Order of Interventions 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to first wear standard, non-free-form, non-customized PAL spectacles, then second, crossover to wear individually customized free-form surfaced PAL spectacles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized Order of Interventions 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized to first wear individually customized free-form surfaced PAL spectacles, then second, crossover to wear standard, non-free-form, non-customized PAL spectacles</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard, non-free-form, non-customized PAL spectacles</intervention_name>
    <description>Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.</description>
    <arm_group_label>Randomized Order of Interventions 1</arm_group_label>
    <arm_group_label>Randomized Order of Interventions 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Individually customized free-form surfaced PAL spectacles</intervention_name>
    <description>Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt</description>
    <arm_group_label>Randomized Order of Interventions 1</arm_group_label>
    <arm_group_label>Randomized Order of Interventions 2</arm_group_label>
    <other_name>Zeiss Individual, Carl Zeiss Vision, Inc., Germany</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presbyope

          -  Experienced PAL spectacle wearer

          -  Correctable to at least 20/25 in both eyes

          -  Able and willing to use Test and Control spectacles for 1 week each as primary form of
             presbyopia correction

          -  Able and willing to complete all laboratory measurements and questionnaire batteries

        Exclusion Criteria:

          -  Purchasing free-form PAL spectacles from the UC Berkeley Eyewear Center

          -  Having eye conditions or diseases that could potentially cause a decrease in visual
             acuity over the course of participation in the study

          -  Having eye conditions or diseases that could potentially interfere with ability to use
             Test and Control spectacles as primary form of presbyopia correction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>39 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meng C. Lin, OD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Center, School of Optometry, University of California, Berkeley</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Center, School of Optometry, University of California, Berkeley</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94720-2020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Han SC, Graham AD, Lin MC. Clinical assessment of a customized free-form progressive add lens spectacle. Optom Vis Sci. 2011 Feb;88(2):234-43. doi: 10.1097/OPX.0b013e31820846ac.</citation>
    <PMID>21217408</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2010</study_first_submitted>
  <study_first_submitted_qc>November 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <results_first_submitted>June 27, 2013</results_first_submitted>
  <results_first_submitted_qc>April 17, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 18, 2017</results_first_posted>
  <last_update_submitted>April 17, 2017</last_update_submitted>
  <last_update_submitted_qc>April 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Berkeley</investigator_affiliation>
    <investigator_full_name>Meng C. Lin</investigator_full_name>
    <investigator_title>Director, Clinical Research Center</investigator_title>
  </responsible_party>
  <keyword>Progressive addition lenses</keyword>
  <keyword>Customized free-form</keyword>
  <keyword>Presbyopia</keyword>
  <keyword>Bifocals</keyword>
  <keyword>Subjective assessment</keyword>
  <keyword>Visual performance</keyword>
  <keyword>Visual acuity</keyword>
  <keyword>Amsler grid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Presbyopic subjects were recruited from the population of patients who were purchasing non-free-form PAL spectacles with antireflective coating in new frames from the University of California, Berkeley School of Optometry Eyewear Center.</recruitment_details>
      <pre_assignment_details>95 subjects were recruited, all of whom met the eligibility criteria and completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group 1 - Control Spectacles Worn First, Then Test Spectacles</title>
          <description>Crossover trial; 2 arms: subjects randomized to wear Control spectacles 1st, then Test spectacles 2nd</description>
        </group>
        <group group_id="P2">
          <title>Group 2 - Test Spectacles Worn First, Then Control Spectacles</title>
          <description>Crossover trial; 2 arms: subjects randomized to wear Test spectacles 1st, then Control spectacles 2nd</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>1-Week Washout Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Crossover trial: all study participants received both Test and Control spectacles, in randomized order.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="95"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.1" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity, High Contrast, Distance Chart</title>
        <description>Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity, High Contrast, Distance Chart</title>
          <description>Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.06"/>
                    <measurement group_id="O2" value="-0.11" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity, Low Contrast, Distance Chart</title>
        <description>Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity, Low Contrast, Distance Chart</title>
          <description>Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.07"/>
                    <measurement group_id="O2" value="0.01" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity, High Contrast, Near Chart</title>
        <description>Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity, High Contrast, Near Chart</title>
          <description>Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.13"/>
                    <measurement group_id="O2" value="-0.09" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity, Low Contrast, Near Chart</title>
        <description>Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity, Low Contrast, Near Chart</title>
          <description>Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&amp;S Technologies Smart System II visual acuity projection system.</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.09"/>
                    <measurement group_id="O2" value="0.12" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>30-degree Off-axis Distance Visual Acuity, High Contrast Chart</title>
        <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
        </group_list>
        <measure>
          <title>30-degree Off-axis Distance Visual Acuity, High Contrast Chart</title>
          <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Off-Axis Left</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.13"/>
                    <measurement group_id="O2" value="0.10" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Off-Axis Right</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.09"/>
                    <measurement group_id="O2" value="0.04" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>30-degree Off-axis Distance Visual Acuity, Low Contrast Chart</title>
        <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
        </group_list>
        <measure>
          <title>30-degree Off-axis Distance Visual Acuity, Low Contrast Chart</title>
          <description>Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Off-Axis Left</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.12"/>
                    <measurement group_id="O2" value="0.24" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Off-Axis Right</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.10"/>
                    <measurement group_id="O2" value="0.16" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Horizontal Extent of Undistorted Vision at Reading Distance</title>
        <description>Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid</description>
        <time_frame>Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
        </group_list>
        <measure>
          <title>Horizontal Extent of Undistorted Vision at Reading Distance</title>
          <description>Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.74" spread="9.87"/>
                    <measurement group_id="O2" value="20.06" spread="11.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Questionnaire Battery</title>
        <description>Forced-choice Likert scale preference questionnaire</description>
        <time_frame>At study exit, after both Test and Control spectacles had been worn for 1 week each</time_frame>
        <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
        <group_list>
          <group group_id="O1">
            <title>Control Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
          <group group_id="O2">
            <title>Test Spectacles</title>
            <description>Arm/Groups Outcome Measures are reported &quot;per intervention&quot;</description>
          </group>
        </group_list>
        <measure>
          <title>Questionnaire Battery</title>
          <description>Forced-choice Likert scale preference questionnaire</description>
          <population>95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall Preference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preference for Distance Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preference for Active Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preference for Midrange Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preference for Transitional Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preference for Near Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>9 months (study duration)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control Spectacles</title>
          <description>Arm/Groups Adverse Events are reported &quot;per intervention&quot;</description>
        </group>
        <group group_id="E2">
          <title>Test Spectacles</title>
          <description>Arm/Groups Adverse Events are reported &quot;per intervention&quot;</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Possibility of insufficient head immobilization during off-axis VA measurement on left side only for some subjects. May explain difference of off-axis VA results between right and left sides.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Andrew D. Graham</name_or_title>
      <organization>UCaliforniaBerkeley</organization>
      <phone>510-643-9252</phone>
      <email>agraham@berkeley.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

